OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 134 filers reported holding OREXIGEN THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $26,000 | -54.4% | 59,853 | -40.6% | 0.00% | – |
| Q1 2016 | $57,000 | -66.5% | 100,744 | +2.3% | 0.00% | – |
| Q4 2015 | $170,000 | -80.5% | 98,474 | -76.2% | 0.00% | – |
| Q3 2015 | $872,000 | -57.4% | 413,268 | -0.1% | 0.00% | -100.0% |
| Q2 2015 | $2,048,000 | +296.9% | 413,600 | +525.9% | 0.00% | – |
| Q1 2015 | $516,000 | -66.1% | 66,080 | -73.7% | 0.00% | -100.0% |
| Q4 2014 | $1,521,000 | +445.2% | 250,888 | +282.6% | 0.00% | – |
| Q3 2014 | $279,000 | -22.1% | 65,579 | +13.2% | 0.00% | – |
| Q2 2014 | $358,000 | +31.1% | 57,938 | +38.1% | 0.00% | – |
| Q1 2014 | $273,000 | +33.2% | 41,953 | +15.6% | 0.00% | – |
| Q4 2013 | $205,000 | -33.0% | 36,295 | -27.2% | 0.00% | – |
| Q3 2013 | $306,000 | -85.1% | 49,861 | -85.8% | 0.00% | -100.0% |
| Q2 2013 | $2,052,000 | – | 351,033 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 5,427,559 | $2,334,000 | 1.60% |
| Scale Management, LLC | 1,312,575 | $564,000 | 1.34% |
| Foresite Capital Management III, LLC | 2,542,575 | $1,093,000 | 0.75% |
| BVF INC/IL | 5,252,100 | $2,258,000 | 0.48% |
| TIVERTON ASSET MANAGEMENT LLC | 45,313 | $4,261,000 | 0.18% |
| Baupost Group | 22,268,399 | $9,575,000 | 0.13% |
| Rhenman & Partners Asset Management AB | 1,200,000 | $516,000 | 0.09% |
| NEA Management Company, LLC | 370,900 | $1,595,000 | 0.08% |
| SAMLYN CAPITAL, LLC | 6,160,417 | $2,649,000 | 0.06% |
| Palo Alto Investors LP | 1,673,024 | $719,000 | 0.05% |